ストックスクリーナーアプリを入手
1.03
3.74%
-0.04
前日終値:
$1.07
開ける：
$1.08
24時間の取引高:
1.29M
Relative Volume:
1.04
時価総額：
$111.73M
収益：
$4.35M
当期純損益:
$-45.53M
株価収益率:
-0.9537
EPS:
-1.08
ネットキャッシュフロー:
$-44.79M
1週間 パフォーマンス:
-24.82%
1か月 パフォーマンス:
+3.26%
6か月 パフォーマンス:
-21.97%
1年 パフォーマンス:
+23.26%
1日の値動き範囲:
$1.03
$1.0875
1週間の範囲:
$1.01
$1.3864
52週間の値動き範囲:
$0.73
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
LUCD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.03 | 103.93M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-27 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 開始されました | BTIG Research | Buy |
| 2021-11-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 開始されました | Needham | Buy |
Lucid Diagnostics Inc (LUCD) 最新ニュース
Lucid Diagnostics, New York, closes public offering of common stock - Medical Buyer
Duke University to License Endoscopic Esophageal Imaging Tech to PAVmed - Medical Product Outsourcing
Lucid Diagnostics dips after pricing $25M stock offering - MSN
Lucid Diagnostics Completes Public Offering for $26.9 Million - The Globe and Mail
Alyeska Investment Group L.P. Makes New $2.81 Million Investment in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Public Stock Offering - MSN
Lucid Diagnostics announces closing of public offering of common stock - MarketScreener
Lucid Diagnostics Closes Roughly $26.9 Million Stock Offering - MarketScreener
PAVmed’s Lucid Diagnostics Completes Public Stock Offering - TipRanks
$26.9M Capital Raise: Cancer Diagnostics Firm Lucid Completes Major Public Offering at $1.00 Per Share - Stock Titan
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise - Investing.com Canada
Lucid Diagnostics Prices $25 Mln Public Offering At $1.00 Per Share - Nasdaq
Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering - 富途牛牛
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise By Investing.com - Investing.com South Africa
Lucid Diagnostics prices $25 million public offering of common stock - Investing.com
Lucid Prices Public Share Offering - Baystreet.ca
Lucid Diagnostics Prices $25 Million Public Offering - MarketScreener
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PR Newswire
Lucid Diagnostics prices $25 million public offering of common stock By Investing.com - Investing.com UK
Lucid Diagnostics announces pricing of public offering of common stock - MarketScreener
$25 Million Stock Offering: Cancer Diagnostics Firm Lucid Diagnostics Raises Fresh Capital at $1/Share - Stock Titan
Lucid Diagnostics announces proposed public offering of common stock By Investing.com - Investing.com Australia
Lucid Diagnostics Plans Stock Offering - MarketScreener
Medical Diagnostics Company Lucid Diagnostics Plans New Stock Offering to Fund Growth - Stock Titan
Sentiment Watch: What’s the MACD signal for Lucid Diagnostics Inc.Quarterly Performance Summary & Long-Term Growth Stock Strategies - Lancaster City Council
Is Lucid Diagnostics Inc. stock forming a cup and handleQuarterly Trade Summary & Technical Buy Zone Confirmations - beatles.ru
Transcript : Lucid Diagnostics Inc.Special Call - MarketScreener
Lucid Diagnostics Advances Towards Medicare Coverage - MSN
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - BioSpace
Will Lucid Diagnostics Inc. outperform during market ralliesRate Cut & Weekly Top Gainers Trade List - خودرو بانک
Lucid Diagnostics stock rises as Canaccord reiterates Buy rating By Investing.com - Investing.com Nigeria
Detecting support and resistance levels for Lucid Diagnostics Inc.Rate Hike & AI Powered Buy and Sell Recommendations - Newser
Will Lucid Diagnostics Inc. bounce back from current supportJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
How to build a custom watchlist for Lucid Diagnostics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Needham reiterates Buy rating on Lucid Diagnostics stock after positive CAC meeting - Investing.com Nigeria
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage By Investing.com - Investing.com Canada
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage - Investing.com India
Lucid Diagnostics To Host Investor Call On Monday, September 8, 2025 - Barchart.com
BTIG raises Lucid Diagnostics stock price target to $2.50 on positive CMS meeting By Investing.com - Investing.com South Africa
Will Lucid Diagnostics Inc. continue its uptrendCEO Change & Weekly Market Pulse Updates - Newser
BTIG raises Lucid Diagnostics stock price target to $2.50 on positive CMS meeting - Investing.com India
Lucid Diagnostics stock rises as Canaccord reiterates Buy rating - Investing.com
Published on: 2025-09-05 05:06:12 - Newser
Ghisallo Capital Management LLC Makes New Investment in Lucid Diagnostics Inc. $LUCD - MarketBeat
Strategies to average down on Lucid Diagnostics Inc.2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
How to read the order book for Lucid Diagnostics Inc.2025 Trade Ideas & High Conviction Investment Ideas - Newser
Lucid Diagnostics Inc (LUCD) 財務データ
収益
当期純利益
現金流量
EPS
Lucid Diagnostics Inc (LUCD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
1.14%
1.01%
大文字化:
|
ボリューム (24 時間):